Previous studies have revealed that the quantity and function of EPCs in COPD patients might decrease, and increasing p16 expression plays an important role in maintaining characteristic cell cycle arrest [26–28]. This evidence concerns the gene CDKN2A and chronic obstructive pulmonary disease.